By Regulatory Approvals — FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma The American Journal of Managed Care
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 21, 2026.